NGT3, Next Generation Technologies: medical device and life science technologies – established in 2013, located in Nazareth, IIA-supported. The incubator originated from NGT, which operates as technological incubator since 2002. Funds to the incubator are raised from European, American and Israeli investors with track records in the healthcare space.
NGT3's portfolio of companies includes eleven early stage companies, primarily in innovative medical devices and life sciences. Notable investments were made into PamBio (drug therapy for acute bleeding conditions), Parasonic (home-use device for removing head lice), Aqueduct and Guide In Medical (guided intubation systems). The incubator expects three exits via M&As during 2018.
NGT3 added two companies to its portfolio in 2017: EIO Biomedical (developing a unique solution for surgical adhesion preventions), and Barcode Diagnostics (developing a personal cancer drug screening).
|Wadi El Haj 13 P.O. Box 1252, Nazareth 17111 Israel|
|+972 4 656 4118|
|+972 4 609 8600|
To update your company data, click here.